138 related articles for article (PubMed ID: 34191272)
1. Correlation analysis of CT-based rectal planning dosimetric parameters with in vivo dosimetry of MOSkin and PTW 9112 detectors in Co-60 source HDR intracavitary cervix brachytherapy.
Jamalludin Z; Malik RA; Ung NM
Phys Eng Sci Med; 2021 Sep; 44(3):773-783. PubMed ID: 34191272
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during
Jamalludin Z; Jong WL; Malik RA; Rosenfeld AB; Ung NM
Phys Med; 2020 Jan; 69():52-60. PubMed ID: 31830631
[TBL] [Abstract][Full Text] [Related]
3. Characterization of MOSkin detector for in vivo dose verification during Cobalt-60 high dose-rate intracavitary brachytherapy.
Jamalludin Z; Jong WL; Abdul Malik R; Rosenfeld A; Ung NM
Phys Med; 2019 Feb; 58():1-7. PubMed ID: 30824140
[TBL] [Abstract][Full Text] [Related]
4. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
5. In vivo dosimetry using MOSkin detector during Cobalt-60 high-dose-rate (HDR) brachytherapy of skin cancer.
Jamalludin Z; Jong WL; Ho GF; Rosenfeld AB; Ung NM
Australas Phys Eng Sci Med; 2019 Dec; 42(4):1099-1107. PubMed ID: 31650362
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy.
Carrara M; Romanyukha A; Tenconi C; Mazzeo D; Cerrotta A; Borroni M; Cutajar D; Petasecca M; Lerch M; Bucci J; Richetti A; Presilla S; Fallai C; Gambarini G; Pignoli E; Rosenfeld A
Phys Med; 2017 Sep; 41():5-12. PubMed ID: 28499627
[TBL] [Abstract][Full Text] [Related]
7. In-vivo Comparison of Planned and Measured Rectal Doses during Cobalt-60 HDR CT-based Intracavitary Brachytherapy Applications of Cervical Cancer Using the PTW 9112 Semiconductor Probe.
Johan SK; Lobo D; Athiyamaan MS; Srinivas C; Banerjee S; Abhishek K; Saxena PUP
Asian Pac J Cancer Prev; 2023 Mar; 24(3):897-907. PubMed ID: 36974543
[TBL] [Abstract][Full Text] [Related]
8. Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters.
Poder J; Howie A; Brown R; Bucci J; Rosenfeld A; Enari K; Schreiber K; Carrara M; Bece A; Malouf D; Cutajar D
Radiother Oncol; 2020 Oct; 151():273-279. PubMed ID: 32798597
[TBL] [Abstract][Full Text] [Related]
9. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
Rangarajan R; Subramanian S; Gopalakrishnan K
Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
[TBL] [Abstract][Full Text] [Related]
10. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
11. Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.
Legge K; Greer PB; O'Connor DJ; Wilton L; Richardson M; Hunter P; Wilfert A; Martin J; Rosenfeld A; Cutajar D
Radiat Oncol; 2017 Feb; 12(1):41. PubMed ID: 28241841
[TBL] [Abstract][Full Text] [Related]
12. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
13. In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses.
Carrara M; Tenconi C; Rossi G; Borroni M; Cerrotta A; Grisotto S; Cusumano D; Pappalardi B; Cutajar D; Petasecca M; Lerch M; Gambarini G; Fallai C; Rosenfeld A; Pignoli E
Radiother Oncol; 2016 Jan; 118(1):148-53. PubMed ID: 26796593
[TBL] [Abstract][Full Text] [Related]
14. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
[TBL] [Abstract][Full Text] [Related]
15. Non isocentric film-based intracavitary brachytherapy planning in cervical cancer: a retrospective dosimetric analysis with CT planning.
Tyagi K; Mukundan H; Mukherjee D; Semwal M; Sarin A
J Contemp Brachytherapy; 2012 Sep; 4(3):129-34. PubMed ID: 23346141
[TBL] [Abstract][Full Text] [Related]
16. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
17. In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.
Waldhäusl C; Wambersie A; Pötter R; Georg D
Radiother Oncol; 2005 Dec; 77(3):310-7. PubMed ID: 16226818
[TBL] [Abstract][Full Text] [Related]
18. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy.
Jamema SV; Saju S; Mahantshetty U; Pallad S; Deshpande DD; Shrivastava SK; Dinshaw KA
J Med Phys; 2008 Jan; 33(1):3-8. PubMed ID: 20041045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of variation of interfraction doses to organs at risk during brachytherapy of cervical cancer.
Mukundan H; Tyagi K; Mukherjee D; Patel RK
Med J Armed Forces India; 2020 Apr; 76(2):201-206. PubMed ID: 32476719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
